<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Royal (Dick) School of Veterinary Scienc</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1C2EEA30-8EDC-4335-B896-240E712D2D9C"><gtr:id>1C2EEA30-8EDC-4335-B896-240E712D2D9C</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:otherNames>Andrew</gtr:otherNames><gtr:surname>Mabbott</gtr:surname><gtr:orcidId>0000-0001-7395-1796</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FF019726%2F1"><gtr:id>3ED88C1E-27DE-4321-98B6-F6E4A64B1F6A</gtr:id><gtr:title>Determining the role of CXCR5-expressing dendritic cells in immune function and TSE agent neuroinvasion from the intestine</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/F019726/1</gtr:grantReference><gtr:abstractText>Transmissible spongiform encephalophathies (TSEs) are prolonged diseases which cause extensive degeneration in the brain. In the absence of a cure these diseases are invariably fatal. These diseases affect both animals and humans, and include Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform encephalopathy ('mad cow disease') in cattle, chronic wasting disease in mule deer and elk, and scrapie in sheep and goats. Some animal species and humans have become infected with these diseases after eating TSE agent-contaminated food, or through transplantation of TSE agent-contaminated tissues or tissue products (eg: transfusion of blood from a variant CJD-infected donor). Many questions remain concerning the route the infectious TSE agent takes from the site of exposure (eg: intestine) to the brain where it causes damage to nerve cells. We have shown that soon after inoculation TSE agents first target and accumulate within lymphoid tissues (Peyer's patches in the intestine, lymph nodes and spleen) before they spread to the brain. Many TSE agents must accumulate in these lymphoid tissues before they can subsequently gain access to the brain (a process termed neuroinvasion) where they ultimately cause neurodegeneration and death. How TSE agents are delivered from the intestine to the lymphoid tissues where they accumulate before neuroinvasion is not known. The identification of the cells or mechanisms involved in TSE agent transport may identify an important process to which treatments can be directed to block neuroinvasion. Therefore, the aim of the research in this proposal is to study this important missing link and determine the mechanism/s involved in the initial delivery of TSE agents to lymphoid tissues. Migratory dendritic cells (DCs) continually circulate throughout the body. These sentinel cells sample foreign particles and microbes and deliver them to the lymphoid tissues to initiate an appropriate immune response. Our recent data suggest that migratory DCs also play a key role in the transportation of the TSE agents from intestine to the lymphoid tissues. However, whether DCs transfer TSE agents directly to the cells within the lymphoid tissues from which neuroinvasion subsequently occurs is not known. The status of DC is strongly influenced by the microbial contents and inflammatory conditions in the intestine, suggesting that these factors are likely to dramatically affect susceptibility to orally-acquired TSE agents. Therefore, further experiments are necessary to determine the precise role that DCs play in the early stages of TSE pathogenesis. Stimulation from chemokines through chemokine receptors play important roles in attracting cells such as DCs to lymphoid tissues and determining their location within them. For example, the chemokine CXCL13 is expressed within in B cell follicles and attracts cells that express the CXCR5 chemokine receptor into them. The follicular dendritic cells that reside within B cell follicles produce high levels of CXCL13 are critical sites of TSE agent accumulation within lymphoid tissues. Therefore, the major aim of the research in this proposal is to assess the role of CXCR5-expressing DCs in immune function and TSE agent neuroinvasion from the intestine. Specifically, the hypothesis will be tested that in the absence of CXCR5-expressing DCs, these DCs are unable to deliver the TSE agent to the FDCs within the B cell follicles of lymphoid tissues, and as a consequence, TSE agent neuroinvasion is blocked. A thorough understanding of the early events in TSE pathogenesis will aid the determination of risk and the development pre-clinical diagnostics and therapeutics.</gtr:abstractText><gtr:technicalSummary>After oral exposure many transmissible spongiform encephalopathy (TSE) agents accumulate first upon follicular dendritic cells (FDCs) in the gut-associated lymphoid tissues (GALT). We have shown that TSE agent accumulation in the GALT, especially Peyer's patches, is obligatory for the transmission of disease to the brain. However, the mechanism through which TSE agents are initially conveyed from the gut lumen to the FDCs within the GALT is not known. Our recent data suggest that migratory dendritic cells (DCs, a distinct lineage from stromal-derived FDCs) play a key role in the translocation of the TSE agents from the gut lumen to the GALT. However, whether DCs transfer TSE agents directly to the FDCs from which neuroinvasion subsequently occurs is not known. As DC status is strongly influenced by microbial stimuli and inflammatory conditions in the intestine, these factors are likely to dramatically affect susceptibility to orally acquired TSE agents. Therefore, further experiments are necessary to determine the precise role that DCs play in the early stages of TSE pathogenesis. Chemokines and chemokine receptors play important roles in attracting lymphocytes and DCs to lymphoid tissues and controlling their positioning within them. The chemokine CXCL13 is expressed by FDCs and follicular stromal cells in B cell follicles and attracts CXCR5-expressing cells into them. The major aim, therefore, of the research in this proposal is to assess the role of CXCR5-expressing DCs in immune function and TSE agent neuroinvasion from the intestine. A unique transgenic mouse line will be generated that lacks CXCR5-expressing DCs. These mice will be used to test the specific hypothesis that in the absence of CXCR5-expressing DCs, TSE agent accumulation upon FDCs in the GALT is blocked and neuroinvasion impaired. A thorough understanding of the early events in TSE pathogenesis will aid the determination of risk and the development pre-clinical diagnostics and therapeutics.</gtr:technicalSummary><gtr:fund><gtr:end>2012-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>369537</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Keeping bugs at Bay: a Public Engagement Activity at the Royal Highland Show 2015</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F98109EE-A201-436B-AD27-F3ECAC31889D</gtr:id><gtr:impact>This activity aims to teach people how the immune system fights bugs.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Keeping bugs at Bay: a Public Engagement Activity at the Roslin Institute 2014</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>78132AE0-CF97-4C9C-8C39-A7F42E06C649</gtr:id><gtr:impact>This activity aims to teach people how the immune system fights bugs.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>3000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Study of the role of macrophages in prion disease pathogenesis</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>University of Edinburgh</gtr:fundingOrg><gtr:fundingRef>GR002413</gtr:fundingRef><gtr:id>E052004B-4B0E-4156-87A9-2E6C468E2E91</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have successfully created a unique transgenic mouse line enabling the conditional ablation of the CXCR5 gene in macrophages and dendritic cells.

After oral exposure to prions, the early replication of certain prion strains upon follicular dendritic cells (FDC) in the Peyer's patches in the small intestine is important for the efficient spread of disease to the brain (termed neuroinvasion). However, little is known of how prions are initially conveyed from the lumen of the gut to the FDC. Our data suggest prions are initially acquired from the gut lumen by M cells in the epithelia overlying the Peyer's patches. Following their transcytosis by M cells, particles and microorganisms typically exit into the intraepithelial pocket on the basolateral membrane where they are subsequently processed by the underlying leukocytes and lymphocytes. Migratory bone marrow-derived conventional dendritic cells (cDC) are centrally involved in the transport of antigens both within Peyer's patches and on into the mesenteric lymph nodes. A subset of cDC has also been identified that can migrate into the B cell follicles where FDC reside. We have previously show that in the transient absence of CD11c+ mononuclear phagocytes (such as cDC) at the time of oral exposure, the accumulation of prions in the Peyer's patches is impeded and disease susceptibility reduced. However, whether these mononuclear phagocytes convey prions directly to FDC within the B cell follicles of Peyer's patches is not known. Chemokines play important roles in attracting lymphocytes and leukocytes to lymphoid tissues and controlling their positioning within them. The chemokine CXCL13 is expressed by FDC and modulates the homing of CXCR5-expressing B cells towards them. Certain CD11c+ mononuclear phagocytes also express CXCR5 and can migrate into B cell follicles. We therefore determined whether CXCR5-expressing mononuclear phagocytes convey prions to FDC after oral exposure. Novel compound transgenic mice were created in which CXCR5-deficiency was specifically restricted to CD11c+ mononuclear phagocytes. When these mice were orally exposed to prions our data show that in the absence of CXCR5 expression in mononuclear phagocytes the early accumulation of prions upon FDC in Peyer's patches and the spleen was impaired, and disease susceptibility was significantly reduced. Together, these data suggest that after oral exposure CXCR5-expressing mononuclear phagocytes play an important role in the efficient transfer of prions towards FDC within Peyer's patches. 

Infection with the gastrointestinal nematode Trichuris muris stimulates a TH2 dominated response in resistant mouse strains such as C57Bl/6, and infection is cleared within 21 days. We investigated the ability of CD11c-CXCR5-/- mice to mount an appropriate TH2 response to T. muris infection to facilitate clearance. Unlike wild-type CXCR5 expressing CXCR5fl/fl control mice, CD11c-CXCR5-/- mice were unable to clear T. muris after 30 days. Mouse strains susceptible to T. muris infection display a TH1 dominated response and remain persistently infected. Persistently T. muris infected CD11c-CXCR5-/- mice revealed increases in Interferon ?, IL1?, IL2, IL6, IL10 and reduction in IL4, IL9 and IL25 cytokines when compared to T. muris cleared wild-type mice. Analysis of gene expression in the mesenteric lymph nodes of T. muris infected CD11c-CXCR5-/- mice revealed increases in both IL12 receptor subunits IL12RB1 and IL12RB2 and the co-stimulatory molecules CD80 and CD86. We have demonstrated that CXCR5 deficiency in CD11c+ cells alters the ability to form a coherent TH2 type response to T. muris infection, and further that the T-cell response is relatively unpolarised, displaying increases in both TH1 and TH2 associated markers. These data confirm that for the efficient formation of a TH2 response to infection with intestinal nematodes (either T.muris or H. polygyrus), antigen presenting (CD11c+) cells are required to localise to the B-cell follicle via expression of the chemokine receptor CXCR5.</gtr:description><gtr:exploitationPathways>A thorough understanding of the cells and mechanisms involved in the propagation of prions within the gut will help identify novel factors that influence disease susceptibility or targets for intervention. 

We have successfully created a unique transgenic mouse line enabling the conditional ablation of the CXCR5 gene in cells of interest. These mice have been shared with other scientists around the world for use in their own studies.</gtr:exploitationPathways><gtr:id>0A567EAE-53F3-44E7-B05B-102CA02ECA3A</gtr:id><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have created a novel transgenic mouse line in which the expression of the gene Cxcr5 can be conditionally ablated in target cells. To enable conditional deletion of Cxcr5 in specific cell populations without affecting the CXCL13-CXCR5-dependent events required for normal lymphoid tissue development, mice with a conditional Cxcr5 allele were created by introducing loxP sites flanking exon 2.</gtr:description><gtr:id>8B7A08EB-94F9-48B2-865D-3600506CB317</gtr:id><gtr:impact>Previously, it was necessary to use bone marrow irradiation chimeras to study the in vivo role of Cxcr5-expression conventional dendritic cells. These mice provide a refined method to study the role of Cxcr5-expressing conventional dendritic cells without the requirement to first create bone marrow irradiation chimeras.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CXCR5-flox mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:url>http://jvi.asm.org/content/early/2017/03/02/JVI.00124-17.abstract</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FDB8827A-5D19-4A83-AECE-C9282095DDB9"><gtr:id>FDB8827A-5D19-4A83-AECE-C9282095DDB9</gtr:id><gtr:title>Can DCs be distinguished from macrophages by molecular signatures?</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/33a19c5b757d89036ac7d90155855752"><gtr:id>33a19c5b757d89036ac7d90155855752</gtr:id><gtr:otherNames>Hume DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9885CD95-84AB-4406-8111-01012551F2F6"><gtr:id>9885CD95-84AB-4406-8111-01012551F2F6</gtr:id><gtr:title>Determining the role of mononuclear phagocytes in prion neuroinvasion from the skin.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3d04b1b1ab33f684f37e71d0463f8dec"><gtr:id>3d04b1b1ab33f684f37e71d0463f8dec</gtr:id><gtr:otherNames>Wathne GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/768089C9-7E4A-4B54-ABE2-9EEE0C97A4BE"><gtr:id>768089C9-7E4A-4B54-ABE2-9EEE0C97A4BE</gtr:id><gtr:title>Meta-analysis of lineage-specific gene expression signatures in mouse leukocyte populations.</gtr:title><gtr:parentPublicationTitle>Immunobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0171-2985</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EB8886F9-3AF0-4BE1-8F67-417CCF1B346F"><gtr:id>EB8886F9-3AF0-4BE1-8F67-417CCF1B346F</gtr:id><gtr:title>Homeostatic vs inflammatory replenishment of tissue mononuclear phagocytes revealed by fate mapping CSF1R myeloid precursors</gtr:title><gtr:parentPublicationTitle>EMBO 2013 - Dr Jekyll and Mr Hyde: The Macrophage in Inflammation and Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/269c3d39df627178e68fb2ad36002075"><gtr:id>269c3d39df627178e68fb2ad36002075</gtr:id><gtr:otherNames>Bradford, B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D39B1585-494F-4FCC-ADB5-CE75B06653E4"><gtr:id>D39B1585-494F-4FCC-ADB5-CE75B06653E4</gtr:id><gtr:title>From Scientific Curiosity to Public Enemy Number One in Six Short Months.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4559D87F-EE0A-4669-B743-AA61C855400C"><gtr:id>4559D87F-EE0A-4669-B743-AA61C855400C</gtr:id><gtr:title>The Good, the Bad, and the Ugly of Dendritic Cells during Prion Disease.</gtr:title><gtr:parentPublicationTitle>Journal of immunology research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2314-7156</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F51A753D-4D90-472E-8AC5-810F5E1D1EFD"><gtr:id>F51A753D-4D90-472E-8AC5-810F5E1D1EFD</gtr:id><gtr:title>Involvement of skin DC subsets in TSE transmission</gtr:title><gtr:parentPublicationTitle>Prion 2011</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e6c85ca07b4fdd5cb0c99761434bd20b"><gtr:id>e6c85ca07b4fdd5cb0c99761434bd20b</gtr:id><gtr:otherNames>Wathne, G.J.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B7826EDB-8BD3-4259-A42F-34A735ED2643"><gtr:id>B7826EDB-8BD3-4259-A42F-34A735ED2643</gtr:id><gtr:title>Prospects for safe and effective vaccines against prion diseases.</gtr:title><gtr:parentPublicationTitle>Expert review of vaccines</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1476-0584</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E4271B34-6A55-4B32-AD68-397DDD813476"><gtr:id>E4271B34-6A55-4B32-AD68-397DDD813476</gtr:id><gtr:title>Oral prion disease pathogenesis is impeded in the specific absence of CXCR5-expressing dendritic cells.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e48b28ee4ab00aac6a546646ce68a2b"><gtr:id>4e48b28ee4ab00aac6a546646ce68a2b</gtr:id><gtr:otherNames>Bradford BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C9CA659C-E0E7-46BE-A718-C4AB10B84F76"><gtr:id>C9CA659C-E0E7-46BE-A718-C4AB10B84F76</gtr:id><gtr:title>Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/33F5D6F9-2F03-4A03-83A0-01503F7F70D6"><gtr:id>33F5D6F9-2F03-4A03-83A0-01503F7F70D6</gtr:id><gtr:title>Human prion diseases and the risk of their transmission during anatomical dissection.</gtr:title><gtr:parentPublicationTitle>Clinical anatomy (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e48b28ee4ab00aac6a546646ce68a2b"><gtr:id>4e48b28ee4ab00aac6a546646ce68a2b</gtr:id><gtr:otherNames>Bradford BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0897-3806</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8D86AC64-A288-4194-B468-7B48AA28972C"><gtr:id>8D86AC64-A288-4194-B468-7B48AA28972C</gtr:id><gtr:title>Defining the anatomical localisation of subsets of the murine mononuclear phagocyte system using integrin alpha X (Itgax, CD11c) and colony stimulating factor 1 receptor (Csf1r, CD115) expression fails to discriminate dendritic cells from macrophages.</gtr:title><gtr:parentPublicationTitle>Immunobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e48b28ee4ab00aac6a546646ce68a2b"><gtr:id>4e48b28ee4ab00aac6a546646ce68a2b</gtr:id><gtr:otherNames>Bradford BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0171-2985</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/357CADFA-1717-4E91-9656-27B161244D8A"><gtr:id>357CADFA-1717-4E91-9656-27B161244D8A</gtr:id><gtr:title>CSF-1 receptor-mediated differentiation of a new type of monocytic cell with B cell-stimulating activity: its selective dependence on IL-34.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fa6a907bbdd4b40c61097c9b5118d8f6"><gtr:id>fa6a907bbdd4b40c61097c9b5118d8f6</gtr:id><gtr:otherNames>Yamane F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/139A25E6-3BFB-49F5-B8D4-CC510FC72660"><gtr:id>139A25E6-3BFB-49F5-B8D4-CC510FC72660</gtr:id><gtr:title>The diverse roles of mononuclear phagocytes in prion disease pathogenesis.</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3d04b1b1ab33f684f37e71d0463f8dec"><gtr:id>3d04b1b1ab33f684f37e71d0463f8dec</gtr:id><gtr:otherNames>Wathne GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52E8116F-1F85-4707-87F2-92C9DBAD8C64"><gtr:id>52E8116F-1F85-4707-87F2-92C9DBAD8C64</gtr:id><gtr:title>Peripheral prion disease pathogenesis is unaltered in the absence of sialoadhesin (Siglec-1/CD169).</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e48b28ee4ab00aac6a546646ce68a2b"><gtr:id>4e48b28ee4ab00aac6a546646ce68a2b</gtr:id><gtr:otherNames>Bradford BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/495DC933-4CB4-4E0B-8C69-4228CD2E2124"><gtr:id>495DC933-4CB4-4E0B-8C69-4228CD2E2124</gtr:id><gtr:title>Determining the role of mononuclear phagocytes in prion neuroinvasion from the skin.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3d04b1b1ab33f684f37e71d0463f8dec"><gtr:id>3d04b1b1ab33f684f37e71d0463f8dec</gtr:id><gtr:otherNames>Wathne GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A54E3D55-646E-4E5D-9093-3A8058BDA6D1"><gtr:id>A54E3D55-646E-4E5D-9093-3A8058BDA6D1</gtr:id><gtr:title>Pathway Analysis of Integrin Alpha X/Beta 2 (CD11c/CD18) in the Murine Mononuclear Phagocyte Lineage</gtr:title><gtr:parentPublicationTitle>EMDS, European Macrophage and Dendritic Cell Society. 24th Annual Meeting</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/269c3d39df627178e68fb2ad36002075"><gtr:id>269c3d39df627178e68fb2ad36002075</gtr:id><gtr:otherNames>Bradford, B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4EBDDBB6-5CCA-42A6-B003-6415A47390CB"><gtr:id>4EBDDBB6-5CCA-42A6-B003-6415A47390CB</gtr:id><gtr:title>Prion disease and the innate immune system.</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e48b28ee4ab00aac6a546646ce68a2b"><gtr:id>4e48b28ee4ab00aac6a546646ce68a2b</gtr:id><gtr:otherNames>Bradford BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/21D57DD5-19D1-4B3A-99A0-F0965CA83268"><gtr:id>21D57DD5-19D1-4B3A-99A0-F0965CA83268</gtr:id><gtr:title>The role of CD11c+ cells in TSE agent neuroinvasion from the skin</gtr:title><gtr:parentPublicationTitle>11th International Workshop on Langerhans Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e6c85ca07b4fdd5cb0c99761434bd20b"><gtr:id>e6c85ca07b4fdd5cb0c99761434bd20b</gtr:id><gtr:otherNames>Wathne, G.J.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/832BE1E1-7C99-4E93-99E3-A50BC1F5F3C1"><gtr:id>832BE1E1-7C99-4E93-99E3-A50BC1F5F3C1</gtr:id><gtr:title>Defining anatomical localisation and subsets of the murine mononuclear phagocyte system using integrin alpha X (ITGAX/CD11c) and colony stimulating factor 1 receptor (CSF1-R/CD115) expression fails to discriminate macrophages from dendritic cells</gtr:title><gtr:parentPublicationTitle>15th International Conference of Mucosal Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/269c3d39df627178e68fb2ad36002075"><gtr:id>269c3d39df627178e68fb2ad36002075</gtr:id><gtr:otherNames>Bradford, B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4BD61103-E28F-4352-AC94-793BE2D289A3"><gtr:id>4BD61103-E28F-4352-AC94-793BE2D289A3</gtr:id><gtr:title>Can DCs be distinguished from macrophages by molecular signatures?</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/33a19c5b757d89036ac7d90155855752"><gtr:id>33a19c5b757d89036ac7d90155855752</gtr:id><gtr:otherNames>Hume DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8208212E-CE2C-4A19-9CF8-E1933FCBA5C1"><gtr:id>8208212E-CE2C-4A19-9CF8-E1933FCBA5C1</gtr:id><gtr:title>Prion pathogenesis and secondary lymphoid organs (SLO): tracking the SLO spread of prions to the brain.</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B59D3D4F-451A-4F57-A564-1CB1C3522F22"><gtr:id>B59D3D4F-451A-4F57-A564-1CB1C3522F22</gtr:id><gtr:title>Prion pathogenesis is unaltered following down-regulation of SIGN-R1.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e48b28ee4ab00aac6a546646ce68a2b"><gtr:id>4e48b28ee4ab00aac6a546646ce68a2b</gtr:id><gtr:otherNames>Bradford BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/25C6EA4E-E25E-428C-96EF-95901118C338"><gtr:id>25C6EA4E-E25E-428C-96EF-95901118C338</gtr:id><gtr:title>The functional maturation of M cells is dramatically reduced in the Peyer's patches of aged mice.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/33342a95a5440ee213f0804af9129157"><gtr:id>33342a95a5440ee213f0804af9129157</gtr:id><gtr:otherNames>Kobayashi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/093560A2-A111-4FF5-B2FE-F176C064BAA6"><gtr:id>093560A2-A111-4FF5-B2FE-F176C064BAA6</gtr:id><gtr:title>Knockout of sialoadhesin enhances microglial accumulation during prion pathogenesis</gtr:title><gtr:parentPublicationTitle>10th European Congress of Neuropathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/269c3d39df627178e68fb2ad36002075"><gtr:id>269c3d39df627178e68fb2ad36002075</gtr:id><gtr:otherNames>Bradford, B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A559FB2F-3AA6-4E22-B3E7-CE496AA3E3D8"><gtr:id>A559FB2F-3AA6-4E22-B3E7-CE496AA3E3D8</gtr:id><gtr:title>Determining the influence of the host immune system on TSE pathogenesis</gtr:title><gtr:parentPublicationTitle>EBRC Launch</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7b32c6588e86101875805ed943e120df"><gtr:id>7b32c6588e86101875805ed943e120df</gtr:id><gtr:otherNames>MAbbott, N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6EE60B6A-D5AF-4FDD-BD77-24565C8A87AF"><gtr:id>6EE60B6A-D5AF-4FDD-BD77-24565C8A87AF</gtr:id><gtr:title>The diverse roles of mononuclear phagocytes in prion disease pathogenesis.</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3d04b1b1ab33f684f37e71d0463f8dec"><gtr:id>3d04b1b1ab33f684f37e71d0463f8dec</gtr:id><gtr:otherNames>Wathne GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/F019726/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>